1. Home
  2. INTT vs KPTI Comparison

INTT vs KPTI Comparison

Compare INTT & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$16.80

Market Cap

175.3M

Sector

Technology

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$8.56

Market Cap

197.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTT
KPTI
Founded
1981
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
175.3M
197.3M
IPO Year
1997
2013

Fundamental Metrics

Financial Performance
Metric
INTT
KPTI
Price
$16.80
$8.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
7
Target Price
$13.50
$16.00
AVG Volume (30 Days)
238.5K
527.9K
Earning Date
05-05-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$66,801,000.00
$146,067,000.00
Revenue This Year
$15.82
N/A
Revenue Next Year
$9.10
$22.36
P/E Ratio
N/A
N/A
Revenue Growth
66.06
0.57
52 Week Low
$5.56
$3.65
52 Week High
$19.75
$10.99

Technical Indicators

Market Signals
Indicator
INTT
KPTI
Relative Strength Index (RSI) 57.30 56.09
Support Level $7.33 $5.84
Resistance Level N/A $9.00
Average True Range (ATR) 1.43 0.64
MACD 0.09 0.07
Stochastic Oscillator 42.72 55.35

Price Performance

Historical Comparison
INTT
KPTI

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: